Return to homepagePandemic Pact

SABS-TILDA: COVID19 specific AntiBodieS in The Irish LongituDinal Study on Ageing (TILDA): an opportunity to assess COVID-19 rates and phenotypes in older adults in Ireland

  • Funded by HRB Ireland, Irish Research Council
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $235,852.5

  • Funder

    HRB Ireland, Irish Research Council

  • Principal Investigator

    Dr. Nollaig Bourke

  • Research Location

    Ireland

  • Lead Research Institution

    TCD

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease susceptibility

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Older adults (65 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

We want to learn the 'who' gets COVID19 and 'why' among older people in Ireland. We'll investigate who was infected using the Irish Longitudinal Study on Ageing (TILDA) by measuring virus specific antibody levels and explore what risk factors are associated with disease, including analysis of how the immune system is activated in these people'